GNE7915 - Moligand™, ≥98% , Inhibitor of leucine rich repeat kinase 2;Inhibitor of TTK protein kinase, CAS No.1351761-44-8, Inhibitor of leucine rich repeat kinase 2;Inhibitor of TTK protein kinase

CAS: 1351761-44-8 Cat. No.: G275946 Formula: C19H21F4N5O3 Molecular Weight: 443.4
AVAILABLE TO ORDER
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%
Synonyms
[4-[[4-(Ethylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino]-2-fluoro-5-methoxyphenyl]-4-morpholinyl-methanone|(4-((4-(ethylamino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-fluoro-5-methoxyphenyl)(morpholino)methanone
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Size
Germany (EU)
USA*
Price
Qty
5mg
G275946-5mg
—
3 In stock
€51.11
10mg
G275946-10mg
—
3 In stock
€89.29
25mg
G275946-25mg
—
2 In stock
€195.15
50mg
G275946-50mg
—
2 In stock
€351.35
100mg
G275946-100mg
—
2 In stock
€448.53
Enter a quantity for the sizes you want to add.

Overview

Shipped at room temperature. Store at -20°C.

Specifications

Synonyms
[4-[[4-(Ethylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino]-2-fluoro-5-methoxyphenyl]-4-morpholinyl-methanone | (4-((4-(ethylamino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-fluoro-5-methoxyphenyl)(morpholino)methanone
Specifications & Purity
Moligand™, ≥98%
Biochemical and Physiological Mechanisms
Potent and selective, brain penetrant LRRK2 inhibitor (IC 50 = 9 nM; K i = 1nM). Tested against a panel of 187 kinases only one was inhibited >50% at 100 nM. Displays moderate 5-HT2B anatagonist activity in vitro .
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Grade
Moligand™
Action Type
INHIBITOR
Mechanism of action
Inhibitor of leucine rich repeat kinase 2;Inhibitor of TTK protein kinase
Note
Toxic, refer to SDS for further information Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Purity
≥98%
Names and Identifiers
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/504771697
SMILES
CCNC1=NC(=NC=C1C(F)(F)F)NC2=C(C=C(C(=C2)F)C(=O)N3CCOCC3)OC
IUPAC Name
[4-[[4-(ethylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino]-2-fluoro-5-methoxyphenyl]-morpholin-4-ylmethanone
InChIKey
XCFLWTZSJYBCPF-UHFFFAOYSA-N
InChI
1S/C19H21F4N5O3/c1-3-24-16-12(19(21,22)23)10-25-18(27-16)26-14-9-13(20)11(8-15(14)30-2)17(29)28-4-6-31-7-5-28/h8-10H,3-7H2,1-2H3,(H2,24,25,26,27)
Isomeric SMILES
CCNC1=NC(=NC=C1C(F)(F)F)NC2=C(C=C(C(=C2)F)C(=O)N3CCOCC3)OC
Molecular Weight
443.4
Reaxys
22058142
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=22058142&ln=

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassBenzenoids
ClassBenzene and substituted derivatives
SubclassBenzoic acids and derivatives
Intermediate Tree Nodes Halobenzoic acids and derivatives
Direct Parent2-halobenzoic acids and derivatives
Alternative Parents Benzamides  Morpholine carboxylic acids and derivatives  Methoxyanilines  Phenoxy compounds  Anisoles  Benzoyl derivatives  Methoxybenzenes  Alkyl aryl ethers  Aminopyrimidines and derivatives  Fluorobenzenes  Aryl fluorides  Imidolactams  Vinylogous halides  Tertiary carboxylic acid amides  Heteroaromatic compounds  Dialkyl ethers  Azacyclic compounds  Oxacyclic compounds  Alkyl fluorides  Organic oxides  Organofluorides  Amines  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteromonocyclic compounds
Substituents 2-halobenzoic acid or derivatives - Benzamide - Morpholine-4-carboxylic acid or derivatives - Methoxyaniline - Anisole - Benzoyl - Phenoxy compound - Phenol ether - Aniline or substituted anilines - Methoxybenzene - Aminopyrimidine - Alkyl aryl ether - Fluorobenzene - Halobenzene - Aryl fluoride - Aryl halide - Imidolactam - Morpholine - Oxazinane - Pyrimidine - Tertiary carboxylic acid amide - Heteroaromatic compound - Vinylogous halide - Carboxamide group - Organoheterocyclic compound - Carboxylic acid derivative - Dialkyl ether - Ether - Azacycle - Oxacycle - Organohalogen compound - Alkyl fluoride - Organic nitrogen compound - Organofluoride - Hydrocarbon derivative - Organonitrogen compound - Organic oxide - Amine - Organic oxygen compound - Organooxygen compound - Alkyl halide - Aromatic heteromonocyclic compound
DescriptionThis compound belongs to the class of organic compounds known as 2-halobenzoic acids and derivatives. These are benzoic acids or derivatives carrying a halogen atom at the 2-position of the benzene ring.
External Descriptors Not available
3D Structure
Interactive Chemical Structure Model





Associated Targets(Human)
TTK Tchem Dual specificity protein kinase TTK (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
LRRK2 Tchem Leucine-rich repeat serine/threonine-protein kinase 2 (6 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TTK Tchem Dual specificity protein kinase TTK (2978 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALK Tclin ALK tyrosine kinase receptor (7132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LRRK2 Tchem Leucine-rich repeat serine/threonine-protein kinase 2 (6390 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Associated Targets(non-human)
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cynomolgus monkey (4946 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mechanisms of Action
Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot NumberCertificate TypeDateItem
B2208154B2208154Certificate of AnalysisAug 04, 2026 G275946
B2208158B2208158Certificate of AnalysisAug 04, 2026 G275946
B2208162B2208162Certificate of AnalysisAug 04, 2026 G275946
B2208323B2208323Certificate of AnalysisAug 04, 2026 G275946
B2208352B2208352Certificate of AnalysisAug 04, 2026 G275946
Chemical and Physical Properties
SolubilitySoluble in DMSO to 50 mM warming
Molecular Weight443.4
XLogP32.800
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count11
Rotatable Bond Count6
Exact Mass443.158 Da
Monoisotopic Mass443.158 Da
Topological Polar Surface Area88.600 Ų
Heavy Atom Count31
Formal Charge0
Complexity593.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Safety and Hazards(GHS)
Pictogram(s)
Signal
Warning
Hazard Statements

H302:Harmful if swallowed

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

Reaxys
22058142
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=22058142&ln=
Documents & Articles
Solution Calculators
Reviews

Customer Reviews

Application Protocols

Only protocols explicitly provided in the Product Data may be listed. None are provided for this item.

  • Tested applications: Not specified for this item; refer to CoA/Spec Sheet.
  • Recommended concentrations/dilutions: Not specified for this item; refer to CoA/Spec Sheet.
  • Positive controls and assay references: Not specified for this item; refer to CoA/Spec Sheet.

General note:

  • For designing your own protocols, use standard practices for small-molecule tool compounds (e.g., prepare concentrated DMSO stocks, maintain constant vehicle, include appropriate controls). Validate conditions empirically for your assay system.
Biological Roles

Scope: Research/in vitro context only. No medical or clinical claims.

Literature context (general, not item-specific claims):

  • GNE7915 is reported in the scientific literature as a small-molecule kinase inhibitor tool compound. Studies have used it to interrogate signaling cascades and phosphorylation-dependent biomarkers in cellular and biochemical assays.
  • Such tool compounds are valuable for dissecting target function, validating phenotypes, and benchmarking novel chemotypes in structure–activity relationship (SAR) programs. They often serve as positive controls in target engagement assays (e.g., biochemical IC50, cellular pIC50, nanoBRET/thermal shift) and can facilitate pathway mapping via phosphoproteomics.

Best practices when using bioactive tools:

  • Verify target engagement with orthogonal readouts (enzymatic activity, target phosphorylation, proximity assays) and assess selectivity against relevant off-target panels.
  • Examine concentration–response behavior and time dependence to distinguish direct target inhibition from secondary effects (e.g., transcriptional changes or cellular stress at higher concentrations).
  • Evaluate compound stability in assay media and potential adsorption to plastics; use low-binding consumables when working at sub-micromolar levels.

Data integrity:

  • Record batch/lot, exact solvent composition, and final vehicle concentration in all datasets. Include vehicle-only controls and, where applicable, inactive analog controls for mechanistic assignments.
Buffer Applications

Not a buffering reagent. This product is a bioactive small molecule supplied for research assays and screening.

Practical guidance:

  • Prepare working solutions in assay buffers only after first dissolving in an appropriate organic solvent (commonly DMSO) to ensure complete dissolution. Maintain constant vehicle percentage across conditions.
  • If precipitation is observed upon dilution into aqueous buffer, increase the proportion of co-solvent slightly, employ serial dilution in intermediate co-solvent mixtures, or include a low level of non-ionic surfactant (e.g., 0.01–0.1% Tween-20) provided it does not interfere with the assay readout.

Formulation parameters (item-specific buffer pKa ranges, buffering capacity, ionic strength) are not applicable.

Green Alternatives

Context: Green chemistry considerations for this product focus on solvent use and assay setup rather than replacement of the active itself, since it serves as a specific research tool compound.

Opportunities (general guidance):

  • Minimize DMSO volumes by using higher assay concentrations with smaller addition volumes and by adopting automated low-volume dispensing to limit solvent burden.
  • Where compatible, prefer ethanol or aqueous co-solvent systems with minimal DMSO in late dilutions to reduce worker exposure and waste hazard.
  • Use miniaturized assay formats (384/1536-well) to reduce total chemical consumption and waste generation.

Comparison of common stock solvents (general; not item-specific specs):

  • DMSO: High solvency, recyclable in principle; occupational exposure manageable; disposal as organic hazardous waste required.
  • Ethanol: Renewable feedstock, lower toxicity profile; lower solvency for many heteroaromatics; flammable.
  • PEG-400 or Captisol (cyclodextrin solutions): Improved aqueous delivery with potential reduction of organic solvents; assess biological compatibility and assay interference.

Operational green practices:

  • Consolidate shipments and maintain accurate inventory to reduce cold-chain transport frequency.
  • Employ solvent recovery for large-scale screening operations where feasible and validated for purity.

Note: No greener “substitute molecule” is applicable because the molecular structure defines biological activity; solvent and process choices drive the main green-impact levers.

Pharmaceutical Uses

Regulatory/usage status:

  • For research use only. Not for human or veterinary use. No compendial monograph or excipient designation is provided in the Product Data.

Laboratory and preclinical research context (general):

  • Bioactive reference compounds like this are commonly used as positive controls in discovery biology, as benchmarks in structure–activity relationship (SAR) campaigns, and as analytical standards for bioanalytical method development (e.g., LC–MS/MS quantitation in plasma or tissue homogenates) in preclinical research.
  • They may support formulation screening studies at micro-scale (e.g., solvent/co-solvent systems, cyclodextrin complexes) to understand solubility and stability constraints for in vitro and ex vivo experiments.

Manufacturing/CMC relevance:

  • None stated. Specifications for residual solvents, polymorph control, particle size distribution, and stability-indicating methods are Not specified for this item; refer to CoA/Spec Sheet if such attributes are critical to your research workflows.

Important note:

  • No therapeutic, diagnostic, or clinical application is claimed or supported by this listing. All in vivo use, if contemplated in research settings, should be justified by independent literature and governed by institutional approvals; consult the SDS and CoA for safety and material attributes.
Physical Properties

Item-specific specifications:

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point (mp): Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point (bp): Not applicable for a non-volatile bioactive solid; specific value not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not applicable for a solid; not specified for this item.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • logP/logD: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa: Not specified for this item; refer to CoA/Spec Sheet.

General laboratory guidance (literature/good practice; not item-specific specs):

  • Many kinase inhibitors are sparingly soluble in aqueous media and are commonly prepared as concentrated DMSO stocks (e.g., 10–50 mM) and diluted into assay buffers to ≤0.1–0.5% v/v DMSO final.
  • Solubility and solid-state behavior (polymorph, amorphous vs crystalline) can influence dissolution kinetics; sonication and gentle warming (≤37 °C) of DMSO stocks may assist dissolution. Always verify chemical stability under any heating.
  • If aqueous use is required, co-solvent systems (DMSO→buffer), surfactants (e.g., 0.01–0.1% Tween-20), or cyclodextrins may improve apparent solubility; confirm no assay interference.
Quality & Grades

Item-specific quality information:

  • Grade/Purity: Moligand™ (as provided for this catalog entry)

What Moligand™ implies (general description):

  • Moligand™ items are research-grade small molecules intended for screening, target validation, and mechanism-of-action studies. Emphasis is placed on identity confirmation and high organic purity suitable for biochemical and cell-based assays, rather than on low-UV solvent specifications typical of HPLC-grade solvents.
  • Batch documentation typically includes identity verification (e.g., LC–MS and/or NMR) and an assay of purity by LC/UPLC. Exact test methods and acceptance criteria are batch-dependent.

How to use this grade effectively:

  • For quantitative biology/biophysics, verify purity and identity in-house against your tolerance (e.g., ≥95–98% by area) and assess counter-ions/residual solvents when necessary.
  • If your use requires specific attributes (water content, salt form, chiral purity, particle size), request the CoA/Spec Sheet for this batch. Absent explicit values in the Product Data, treat them as: Not specified for this item; refer to CoA/Spec Sheet.

Stabilizers/impurities:

  • Stabilizers, residual metals, or peroxide specifications are: Not specified for this item; refer to CoA/Spec Sheet.

Compliance note:

  • For research use only. Not intended for diagnostic, therapeutic, clinical, or human/animal consumption applications.
Reaction & Applications

This product is supplied as a bioactive reference compound and is not primarily intended as a synthetic reagent or solvent.

Applicable research uses (general, literature-based; not item-specific claims):

  • Tool compound in biochemical and cellular studies to probe kinase-driven signaling pathways. Typically used to evaluate target engagement, downstream biomarker modulation, and selectivity profiling in vitro.
  • Reference standard in analytical method development (e.g., LC–MS/MS quantitation in matrices) and in assay validation.

Not typically applicable:

  • As a reagent in stoichiometric organic transformations, catalysts, or polymerization initiators.

Practical tips (general good practice):

  • Prepare fresh DMSO stocks under inert atmosphere if sensitivity to hydrolysis/oxidation is suspected; aliquot and minimize freeze–thaw cycles to maintain consistency across experiments.
  • Confirm absence of aggregate-based inhibition or assay interference (test with detergent, redox scavengers, or orthogonal readouts) when interpreting biochemical potency data.
Reaction Conditions

Not applicable as a synthetic reagent. This product is supplied as a bioactive reference compound rather than a substrate, catalyst, or solvent.

Assay preparation conditions (general guidance; not item-specific specs):

  • Stock solutions: Commonly prepared in anhydrous DMSO at 10–50 mM, filtered through 0.2 µm PTFE if particulate is present. Verify chemical stability during any gentle warming used to aid dissolution.
  • Working solutions: Dilute into assay buffer to target concentrations while maintaining constant vehicle (typically ≤0.1–0.5% v/v DMSO). Mix thoroughly to avoid local supersaturation and precipitation.
  • Storage of solutions: Keep light-protected aliquots on ice during use; return unused portions promptly to −20 °C. Avoid repeated freeze–thaw.

Expected assay behaviors (general):

  • Potency may shift with protein source, cofactors, and ATP concentration for kinase assays; assess under conditions matching your biological question.
  • Non-specific binding to plastics and serum proteins can reduce free concentration; consider low-binding plastics and determine unbound fraction if quantitative pharmacology is needed.
Safety & Handling

Item-specific safety data:

  • GHS Classification: Not specified for this item; refer to SDS.
  • Signal Word: Not specified for this item; refer to SDS.
  • Hazard Statements (H-codes): Not specified for this item; refer to SDS.
  • Pictograms: Not specified for this item; refer to SDS.

General laboratory precautions (not a substitute for SDS):

  • Handle in a chemical fume hood with appropriate PPE: lab coat, safety glasses, and chemically resistant gloves (e.g., nitrile). Avoid inhalation of dusts and contact with skin/eyes.
  • Prevent exposure to strong oxidizers or acids/bases until compatibility is known. Avoid open flames and high heat during weighing or dissolution.
  • Use dust-minimizing techniques (antistatic measures, weigh boats with covers). Clean spills with inert absorbent; avoid aerosolization.
  • First aid (general): In case of contact, rinse affected area with water for ≥15 minutes and seek medical attention. If inhaled, move to fresh air. If ingested, rinse mouth; do not induce vomiting; seek medical attention. Always follow institutional protocols.
  • Waste disposal: Collect solutions and solids in labeled containers for organic hazardous waste. Do not discharge to drains.

Authoritative data source: Always consult the product’s SDS for definitive hazard classification, exposure controls, and transport information before use.

Solvent Selection

Applicability: As a bioactive small molecule standard, solvent selection typically concerns stock-solution preparation for biochemical or cell-based assays, not bulk reaction media.

Item-specific solubility: Not specified for this item; refer to CoA/Spec Sheet.

General/literature guidance for small-molecule inhibitors (not item-specific specs):

  • Primary solvent: DMSO is the default for concentrated stocks (e.g., 10–50 mM) due to strong solvating power for heteroaromatics and drug-like scaffolds.
  • Secondary solvents (screen if needed): DMF, NMP for difficult solids (laboratory use only); ethanol or isopropanol for less polar scaffolds; 1:1 DMSO:water or DMSO:buffer during titration to reduce precipitation.
  • Aqueous media: Use co-solvent approaches to keep final DMSO ≤0.1–0.5% v/v in sensitive assays. Consider adding 0.01–0.1% non-ionic surfactant to mitigate aggregation artifacts.
  • Avoid: Strongly protic acidic or basic media unless stability is known; oxidative conditions; prolonged light/air exposure if the scaffold contains oxidizable moieties (verify by stability screening).

Quick comparison (general):

  • DMSO: Highest solvency; excellent for freezer-stable stocks; potential biological effects above 0.5–1% v/v.
  • Ethanol: Better biocompatibility; lower solvency; can perturb membranes.
  • Aqueous buffer only: Lowest solvency; risk of precipitation and adsorption losses.

Always confirm solubility and stability of your specific batch before scaling experiments.

Storage & Reconstitution

Item-specific conditions (from Product Data):

  • Storage Conditions (as supplied): Store at −20 °C.
  • Shipped In: Ice chest + Ice pads (cold-chain packaging).

Form and appearance: Not specified for this item; refer to CoA/Spec Sheet.

Reconstitution guidance (general best practice; not item-specific specs):

  • Solvent: Dissolve the solid in anhydrous DMSO to prepare a concentrated stock (e.g., 10–50 mM), unless your CoA specifies an alternative solvent system. If necessary, warm gently (≤37 °C) and vortex/sonicate to aid dissolution.
  • Filtration: If particulate persists, pass through a 0.2 µm PTFE syringe filter. Avoid aqueous filters for DMSO-rich solutions.
  • Aliquoting: Dispense into single-use, light-protected microtubes to minimize headspace and freeze–thaw.
  • Storage of solutions: Store aliquots at −20 °C or below, protected from light and moisture. Track preparation date and concentration on labels.
  • Stability: Solution and solid-state stability are Not specified for this item; refer to CoA/Spec Sheet. Confirm stability experimentally under your specific storage and assay conditions.

Handling notes:

  • Allow vials to equilibrate to room temperature in a desiccated environment before opening to avoid moisture condensation. Reseal promptly with inert gas if long-term storage is anticipated.

Research Use Note: For research use only.

Structure & Identity

Brief overview: This listing is for a bioactive small molecule tool compound supplied under Aladdin’s Moligand™ line.

Item-specific identifiers (from Product Data):

  • SKU: G275946
  • Product Name: GNE7915
  • CAS: 1351761-44-8
  • PubChem CID: 58539171
  • InChIKey: 414154 (as provided)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural features:

  • Item-specific structural descriptors (functional groups, stereochemistry, ring systems): Not specified for this item; refer to CoA/Spec Sheet.

General/literature notes:

  • GNE7915 is reported in the research literature as a small-molecule kinase inhibitor scaffold. Detailed 2D features (heteroaromatic cores, substitution patterns, stereochemistry) should be confirmed from primary literature or the Certificate of Analysis for this batch before structure-dependent experimental design.

Practical identity guidance:

  • For analytical confirmation in your lab, consider orthogonal methods such as HRMS, 1H/13C NMR, and HPLC/UPLC purity profiling. Match spectra against authenticated references or vendor CoA where available.
  • When registering internally, cross-reference by CAS (1351761-44-8) and PubChem CID (58539171) to minimize synonym ambiguity.
Synthetic Utility

This item is a finalized small-molecule tool compound and is not primarily intended as a synthetic building block.

Use-cases that do apply (general):

  • Analytical reference standard for method development and validation in medicinal chemistry programs (e.g., purity tracking of analog series, stability studies, forced-degradation profiling).
  • Positive control in biochemical or biophysical target assays to benchmark new synthetic analogs.

Not typically applicable:

  • As a coupling partner, electrophile/nucleophile handle, or protecting-group reagent in routine organic synthesis. Functional group transformations, named reactions, and retrosynthetic disconnections are generally irrelevant to end-users for this molecule since its structure-specific activity is the focus.

Practical notes:

  • If analog synthesis is ongoing in your lab, retain this compound as a comparator in SAR. Employ parallel purification and matched analytical methods (same column, gradient, detection wavelengths) to ensure apples-to-apples comparisons across a series.
  • For forced-degradation studies, design stress panels (acid/base, oxidative, thermal, photolytic) to map intrinsic liabilities; this informs formulation of assay stocks and storage practices. Ensure all stress work is performed on small aliquots to protect the primary batch.
Target Specificity

Only information from Product Data may be listed here.

  • Target/antigen: Not specified for this item; refer to CoA/Spec Sheet.
  • Mechanism of action: Not specified for this item; refer to CoA/Spec Sheet.
  • Species reactivity/selectivity panel: Not specified for this item; refer to CoA/Spec Sheet.
  • Clone/isotype/epitope (if applicable): Not applicable.

Note: For research planning, consult primary literature corresponding to CAS 1351761-44-8 and PubChem CID 58539171 to understand reported biochemical selectivity. However, such literature details are not part of this product’s certified specification.

Frequently Asked Questions

What is the purity of this product?
This product is supplied at ≥98% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 1351761-44-8, the molecular formula is C19H21F4N5O3, and the molecular weight is 443.4 g/mol. InChIKey XCFLWTZSJYBCPF-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.